| Anna Khananian, | |
|
2100 Douglas Blvd, Roseville, CA 95661-3804 | |
| (209) 532-5524 | |
| Not Available |
| Full Name | Anna Khananian |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Rheumatology |
| Location | 2100 Douglas Blvd, Roseville, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982137287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | A147675 (California) | Primary |
| 174400000X | Specialist | 1739-A147675 (California) | Secondary |
| Entity Name | John Muir Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841407665 PECOS PAC ID: 6608789813 Enrollment ID: O20031226000143 |
News Archive
Researchers participating in the Multidimensional Intervention for Early Osteoarthritis of the Knee (Knee Study) determined that physically inactive, middle-aged people with symptomatic osteoarthritis benefitted equally from strength training regimens, self-management programs, or a combination of the two. Details of this study are available in the January 2010 issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
The voluntary movements we make must be "prepared" in our brain before they are executed. However, be it perfect timing, a false-start, or a delayed reaction, the neural circuitry underlying movement preparation is not well understood.
The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
› Verified 9 days ago
| Entity Name | Sonora Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033100854 PECOS PAC ID: 4284538505 Enrollment ID: O20040316000829 |
News Archive
Researchers participating in the Multidimensional Intervention for Early Osteoarthritis of the Knee (Knee Study) determined that physically inactive, middle-aged people with symptomatic osteoarthritis benefitted equally from strength training regimens, self-management programs, or a combination of the two. Details of this study are available in the January 2010 issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
The voluntary movements we make must be "prepared" in our brain before they are executed. However, be it perfect timing, a false-start, or a delayed reaction, the neural circuitry underlying movement preparation is not well understood.
The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Khananian, 1450 Treat Blvd # 300, Walnut Creek, CA 94597-2168 Ph: (925) 952-2828 | Anna Khananian, 2100 Douglas Blvd, Roseville, CA 95661-3804 Ph: (209) 532-5524 |
News Archive
Researchers participating in the Multidimensional Intervention for Early Osteoarthritis of the Knee (Knee Study) determined that physically inactive, middle-aged people with symptomatic osteoarthritis benefitted equally from strength training regimens, self-management programs, or a combination of the two. Details of this study are available in the January 2010 issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
The voluntary movements we make must be "prepared" in our brain before they are executed. However, be it perfect timing, a false-start, or a delayed reaction, the neural circuitry underlying movement preparation is not well understood.
The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.
Much of medicine is based on what is considered the strongest possible evidence: The placebo-controlled trial. A paper published in the October 19 issue of Annals of Internal Medicine - entitled "What's In Placebos: Who Knows" calls into question this foundation upon which much of medicine rests, by showing that there is no standard behind the standard no standard for the placebo.
› Verified 9 days ago
Mr. Jaspreet Singh Dhanjal, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 2235 Douglas Blvd Ste 510, Roseville, CA 95661 Phone: 916-446-4449 Fax: 916-446-4370 | |
James H. Heykes, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Dr. Lakhvir Kaur, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2 Medical Plaza Dr Ste 200, Roseville, CA 95661 Phone: 916-797-4715 | |
Dr. John T Bakos, M.D., PHD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 729 Sunrise Ave, Suite 610, Roseville, CA 95661 Phone: 916-347-7001 Fax: 916-304-1633 | |
Uma H Gowda, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8 Medical Plaza Dr Ste 300, Roseville, CA 95661 Phone: 916-782-5106 Fax: 916-878-4941 | |
Peter A. Javaheri, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Rani Reddy Vatti, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 |